Back to LGND Stock Lookup

Ligand Pharma (LGND) –

Oct 22, 2014 08:40 AM Roth Affirms Ligand (LGND) at 'Buy' Following Strong Promacta Sales in Q3
Oct 16, 2014 08:30 AM Ligand to Host Analyst Day on November 18th in New York City
Oct 15, 2014 07:03 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 15 Filed by: KOZARICH JOHN W
Oct 14, 2014 01:49 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 10 Filed by: FOEHR MATTHEW W
Oct 10, 2014 03:04 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 09 Filed by: Sabba Stephen L
Oct 10, 2014 02:29 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 09 Filed by: KNOTT DAVID M
Oct 9, 2014 07:04 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 09 Filed by: Aryeh Jason
Oct 9, 2014 01:50 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 07 Filed by: KOZARICH JOHN W
Oct 8, 2014 10:22 AM Roth Maintains Ligand Pharma (LGND) at 'Buy' Following Prelim. Q3 Results
Oct 8, 2014 08:31 AM Ligand Pharma (LGND) Prelim. Q3 Revs, EPS Top Views
Oct 8, 2014 08:30 AM Ligand Reports Third Quarter Revenues and Expected Diluted EPS
Oct 2, 2014 03:00 PM Lemelson Capital Management Fund Tops BarclayHedge Performance List
Oct 1, 2014 06:25 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 01 Filed by: Aryeh Jason
Sep 29, 2014 01:50 PM Form 4 LIGAND PHARMACEUTICALS For: Sep 25 Filed by: Aryeh Jason
Sep 26, 2014 08:30 AM Ligand Earns Milestone Payment Triggered by EU Approval of Merck’s Captisol-enabled NOXAFIL® (posaconazole) Concentrate for Solution for Infusion
Sep 9, 2014 03:33 PM Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch
Sep 9, 2014 08:37 AM Ligand Pharma (LGND) Reports Expanded License Agreement with CURx Pharma
Sep 9, 2014 08:30 AM Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals, Inc.
Sep 5, 2014 09:03 AM Lemelson Capital Management Marks Flagship Fund's Second Anniversary
Aug 28, 2014 11:11 AM Interferon Therapy for HCV Still Expected Strong Amid Daklinza Approval - Roth (LGND) (BMY)
Aug 27, 2014 09:26 AM Roth Comments on Ligand (LGND) Following Approval of Promact sNDA (GSK)
Aug 27, 2014 08:46 AM Ligand Pharma (LGND) Reports FDA Approval of Promacta/Revolade sNDA
Aug 27, 2014 08:00 AM Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta®/Revolade™ For Use in Patients with Severe Aplastic Anemia
Aug 25, 2014 11:48 AM Lemelson Capital Comments on Ligand Pharmaceuticals (LGND) Going Concern Risk
Aug 25, 2014 11:43 AM Lemelson Capital Comments on Large Institutional Selling in Shares of Ligand Pharmaceuticals Amidst Company's Insolvency and Mounting Going Concern Risk
Aug 21, 2014 05:13 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BIOTECHNOLOGY VALUE FUND L P
Aug 18, 2014 05:17 PM Form 8-K LIGAND PHARMACEUTICALS For: Aug 12
Aug 15, 2014 02:52 PM Form 4 LIGAND PHARMACEUTICALS For: Aug 15 Filed by: HIGGINS JOHN L
Aug 15, 2014 09:30 AM Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products
Aug 14, 2014 10:57 AM Roth Remains Positive on Ligand Pharma (LNGD) Following New Licensing Agreement with Avion Pharma
Aug 14, 2014 09:15 AM Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy
Aug 14, 2014 08:01 AM Ligand Pharma (LGND), Avion Pharma Enter Commercial Licensing Arrangement Covering Captisol-Enabled Programs
Aug 14, 2014 08:00 AM Ligand Signs Multi-Program Captisol® License Agreement with Avion Pharmaceuticals
Aug 13, 2014 08:28 AM Form 8-K LIGAND PHARMACEUTICALS For: Aug 12
Aug 13, 2014 08:08 AM Ligand Pharma (LGND) Prices $225M in Conv. Senior Notes; to Buyback ~700K Shares
Aug 13, 2014 08:00 AM Ligand Prices Offering of $225 Million of Convertible Senior Notes
Aug 12, 2014 07:35 AM Marinus Pharma (MRNS) Enters Agreement for Use of Captisol (LGND)
Aug 11, 2014 05:04 PM Form 8-K LIGAND PHARMACEUTICALS For: Aug 11
Aug 11, 2014 04:03 PM Ligand Pharma (LGND) Announces $225M Convetible Notes Offering; Approves $200M Buyback
Aug 11, 2014 04:01 PM Ligand Announces Proposed Offering of $225 Million of Convertible Senior Notes and Announces $200 Million Share Repurchase Program
Aug 5, 2014 05:22 PM Form 10-Q LIGAND PHARMACEUTICALS For: Jun 30
Aug 4, 2014 02:49 PM Lemelson Increases Short Bet on Ligand Pharma (LGND)
Aug 4, 2014 02:46 PM Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information
Aug 4, 2014 02:24 PM Roth Still Positive on Ligand (LGND) Following Q2 Results, ASPIRE Phase 3 Update (AMGN)
Aug 4, 2014 09:32 AM Pre-Open Stock Movers 8/4: (PIKE) (TKMR) (LJPC) Higher; (INSM) (ZGNX) (HK) Lower (more...)
Aug 4, 2014 08:40 AM Ligand Pharmaceuticals, Inc. (LGND) Tops Q2 EPS by 10c; Boosts FY14 Outlook
Aug 4, 2014 08:33 AM Form 8-K LIGAND PHARMACEUTICALS For: Aug 04
Aug 4, 2014 08:30 AM Ligand Reports Second Quarter 2014 Financial Results
Aug 1, 2014 02:35 PM Trading Radar for 08/04: Tenet Health (THC), GT Advanced Tech (GTAT), Broadsoft (BSFT), Avis Budget (CAR), Alleghany (Y) Report
Jul 23, 2014 08:57 AM Ligand (LGND) Pressure on GSK's Promacta Data is Overreaction - Roth Capital

Back to LGND Stock Lookup